Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Pharmaceutical Project Management: What's Really Important and How Can We Do Better?

Session Chair(s)

John Z. Sun, PhD, MBA, PMP

John Z. Sun, PhD, MBA, PMP

Program Lead, Global Clinical Operation, Development

Novartis Pharmaceuticals Corporation, United States

Project management (PM) plays an important role in pharma and biotech companies, but what can we do to further improve, particularly in today's environment? Come and hear the critical findings from a panel of PM practitioners and experts.

This session has been developed by the Project Management Community.

Learning Objective : Discuss which project management practices are more critical to be focused on to ensure project success in the pharmaceutical and biotechnology industry; Recognize what we can learn from other industries and do better for your own teams with innovative solutions.

Speaker(s)

Peter  Harpum, PhD, MSc

Managing Complex Product Development Projects

Peter Harpum, PhD, MSc

Mannaz A/S, United Kingdom

Client Director

Robin G Foldesy, PhD

The Five Core Qualities of Authentic Leaders

Robin G Foldesy, PhD

Quintiles Transnational Corp., United States

Vice President, Strategic Drug Development

Mary Lou  Bell

Meeting the Challenges of Managing Teams and Alliances

Mary Lou Bell

Nimbus Discovery, United States

Head, Portfolio and Program Management

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.